SAR-445611

N/A

Report date: 2023/11/17 17:41:00

Base Information

Drug NameSAR-445611

Drug Alias NameSAR-445611

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)

Mechanisms of ActionC-X3-C motif chemokine receptor 1 antagonists

TargetsC-X3-C motif chemokine receptor 1

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesSanofi

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

ATC CodeN/A